1-6 of 6
Paulo Andre P. Palhares De Miranda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elevate-TN: Impact of First-Year Dose Modifications in Patients with Treatment-Naive Chronic Lymphocytic Leukemia Treated with Acalabrutinib

George Follows, Alessandra Ferrajoli, John C. Byrd, Bob Shaw, Kenji Nozaki, Katherine Stewart, Paulo Andre P. Palhares De Miranda, Jeff P. Sharman
Journal: Blood
Blood (2023) 142 (Supplement 1): 4645.
https://doi.org/10.1182/blood-2023-174767
Published: 2023
Journal Articles

Impact of Baseline Comorbidities and Treatment on Cardiovascular (CV) Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL): Results of a Systematic Literature Review (SLR) of Interventional Trials and a Targeted Literature Review (TLR) of Real-World Observational Studies in CLL

Yen-Chou Chen, Paulo Andre P. Palhares De Miranda, Bersabeh Sile, Grace Fox, Chinenye Chukwu, Javid J. Moslehi, Rupal O'Quinn
Journal: Blood
Blood (2023) 142 (Supplement 1): 6539.
https://doi.org/10.1182/blood-2023-174776
Published: 2023
Journal Articles

Analysis of Ventricular Arrhythmias and Sudden Death with Acalabrutinib from 5 Prospective Clinical Trials

Jeff P. Sharman, Paolo Ghia, Paulo Andre P. Palhares De Miranda, Naghmana Bajwa, Simon Rule, Bob Shaw, John F. Seymour
Journal: Blood
Blood (2023) 142 (Supplement 1): 4643.
https://doi.org/10.1182/blood-2023-174913
Published: 2023
Journal Articles

Patient and Physician Preferences for Fixed-Duration Vs Treatment to Progression Chronic Lymphocytic Leukemia (CLL) Treatments: Results from a Multi-Country Discrete Choice Experiment

Bersabeh Sile, Dahbia Horchi, Bleuenn Rault, Emily Mulvihill, Kathleen Beusterien, Anna Teschemaker, Katherine Stewart, Paulo Andre P. Palhares De Miranda, Xavier Guillaume
Journal: Blood
Blood (2023) 142 (Supplement 1): 6528.
https://doi.org/10.1182/blood-2023-177690
Published: 2023
Journal Articles

Cumulative Review of Hypertension in Patients with Chronic Lymphocytic Leukemia (CLL) and Other Hematologic Malignancies Treated with Acalabrutinib

Alessandra Ferrajoli, George Follows, Yotvat Marmor, Shogheeg Apkarian Bourjlian, Jack Roos, Naghmana Bajwa, Venkata Madhira, Kenji Nozaki, Paulo Andre P. Palhares De Miranda, Krish Patel
Journal: Blood
Blood (2023) 142 (Supplement 1): 1917.
https://doi.org/10.1182/blood-2023-174727
Published: 2023
Journal Articles

Understanding Patient and Physician Perceptions Regarding Treatment-Related Adverse Events in First-Line Chronic Lymphocytic Leukemia (CLL)

Bersabeh Sile, Dahbia Horchi, Bleuenn Rault, Emily Mulvihill, Kathleen Beusterien, Katherine Stewart, Paulo Andre P. Palhares De Miranda, Xavier Guillaume
Journal: Blood
Blood (2023) 142 (Supplement 1): 6546.
https://doi.org/10.1182/blood-2023-177704
Published: 2023